CHOREOATHETOSIS

Clinical trials for CHOREOATHETOSIS explained in plain language.

Never miss a new study

Get alerted when new CHOREOATHETOSIS trials appear

Sign up with your email to follow new studies for CHOREOATHETOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could a common mineral ease rare genetic disorder? zinc trial shows promise

Disease control Completed

This pilot trial tested whether taking oral zinc every day for 6 months is safe and doable for people with GNAO1 disorders, a rare genetic condition that causes movement problems, seizures, and developmental delays. 13 participants aged 6 months to 30 years took zinc acetate. The…

Matched conditions: CHOREOATHETOSIS

Phase: PHASE2 • Sponsor: Children's University Hospital Cologne, Germany • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC

CHOREOATHETOSIS

Get alerted when new CHOREOATHETOSIS trials appear

Could a common mineral ease rare genetic disorder? zinc trial shows promise